A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis

Conclusions
BET or BVS was highly effective and safe for short-term treatment of EoE. The 1 mg (twice daily) dosage was equally effective as the 2 mg twice daily dosage. The majority of patients preferred the effervescent tablet formulation.

ClinicalTrials.gov number
NCT02280616; EudraCT number, 2009-016692-29.

Source: Gut - February 12, 2016 Category: Gastroenterology Authors: Miehlke, S., Hruz, P., Vieth, M., Bussmann, C., von Arnim, U., Bajbouj, M., Schlag, C., Madisch, A., Fibbe, C., Wittenburg, H., Allescher, H. D., Reinshagen, M., Schubert, S., Tack, J., Müller, M., Krummenerl, P., Arts, J., Mueller, R., Dilger, K. Tags: Open access Oesophagus Source Type: research